Pacira | PCRX - Loan Capital

Stock Price
21.00
Daily Change
0.64 3.14%
Monthly
-19.23%
Yearly
-19.54%
Q1 Forecast
19.91

Pacira reported $376.72M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Astellas Pharma JPY 320B 0 Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 39.41B 173M Sep/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
Novo Nordisk DKK 118.94B 29.76B Dec/2025
Pacira USD 376.72M 1.37M Sep/2025
Perrigo USD 3.61B 7.4M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
Xeris Pharmaceuticals USD 219.47M 839K Sep/2025
Zoetis USD 7.07B 1.84B Sep/2025